These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7353695)

  • 1. Development of a reversible vas deferens occlusion device. VII. Physical and microscopic observations after long-term implantation of flexible prosthetic devices.
    Brueschke EE; Kaleckas RA; Wingfield JR; Welsh TJ; Zaneveld LJ
    Fertil Steril; 1980 Feb; 33(2):167-78. PubMed ID: 7353695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New studies with intravasal devices. The soft valve.
    Brueschke EE; Wingfield JR; Zaneveld LJ
    Invest Urol; 1976 Mar; 13(5):359-65. PubMed ID: 1254430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of reversible vas deferens occlusive device: V. Flexible prosthetic devices.
    Brueschke EE; Zaneveld LJ; Rodzen R; Mayerhoffer K; Burns M; Wingfield JR
    Fertil Steril; 1975 Jan; 26(1):40-52. PubMed ID: 1109938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of reversible vas deferens occlusive device: IV. Rigid prosthetic devices.
    Drueschke EE; Zaneveld LJ; Burns M; Rodzen R; Wingfield JR; Maness JH
    Fertil Steril; 1975 Jan; 26(1):29-39. PubMed ID: 1109937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prosthetic vas deferens.
    Brueschke EE; Maness JH; Zaneveld LJ; Rodzen R; Wingfield JR
    Biomed Eng; 1976 Sep; 11(9):314-8. PubMed ID: 974217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a reversible vas deferens occlusive device. VI. Long-term evaluation of flexible prosthetic devices.
    Brueschke EE; Zaneveld LJ; Kaleckas RA; Wingfield JR
    Fertil Steril; 1979 May; 31(5):575-86. PubMed ID: 446781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible occlusive devices.
    Brueschke EE
    J Reprod Med; 1976 Aug; 17(2):103-15. PubMed ID: 822163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contraceptive effect of a novel filtering-type nano-copper complex/polymer composites intra-vas device on male animals.
    Chen ZL; Huang XB; Suo JP; Li J; Sun L
    Int J Androl; 2010 Dec; 33(6):810-7. PubMed ID: 20236368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasectomy and vasovasostomy. II. A comparison of two methods of vasovasostomy: silastic versus chromic stents.
    Urry RL; Thompson J; Cockett AT
    Fertil Steril; 1976 Aug; 27(8):945-50. PubMed ID: 955137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of spermatogenic damage induced at 6 months after ligation of the vas deferens at proximal and distal locations in the rabbit.
    Peng B; Mao Y; Tang XF; Shang Y; Shen CY; Guo Y; Xiang Y; Yang ZW
    Andrologia; 2011 Apr; 43(2):129-38. PubMed ID: 21382067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial studies on a novel filtering-type intra-vas device in male dogs.
    Huang XB; Suo JP; Chen CY; Du QL; Shen JY; Zhou JL
    Contraception; 2010 Apr; 81(4):350-4. PubMed ID: 20227554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An absorbable artificial vas deferens for vasovasotomy.
    Nuwayser ES; Wu TC; Hotchkiss RS; Farcon EE; Hulka JJ; Mohr K; Poddar A
    Trans Am Soc Artif Intern Organs; 1975; 21():523-30. PubMed ID: 1146027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a reversible vas deferens occlusive device. 3. Morphology of the human and dog vas deferens: a study with the scanning electron microscope.
    Brueschke EE; Zaneveld LJ; Rodzen R; Berns D
    Fertil Steril; 1974 Aug; 25(8):687-702. PubMed ID: 4859272
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravas device studies in rabbits: I. Effect of surgical procedures on adrenergic innervation of the vas deferens.
    Polidoro JP; Draft LA; Culver RM
    Contraception; 1976 Oct; 14(4):383-90. PubMed ID: 975824
    [No Abstract]   [Full Text] [Related]  

  • 15. When and why does occlusion of the vas deferens affect the testis?
    Horan AH
    Fertil Steril; 1975 Apr; 26(4):317-28. PubMed ID: 803907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epididymal extravasation following vasectomy as a cause for failure of vasectomy reversal.
    Silber SJ
    Fertil Steril; 1979 Mar; 31(3):309-15. PubMed ID: 437165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of vasectomy and the treatment of male infertility. Role of microsurgery, vasoepididymostomy, and pressure-induced changes of vasectomy.
    Silber SJ
    Urol Clin North Am; 1981 Feb; 8(1):53-62. PubMed ID: 7210354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with an intravas nylon device in rat.
    Jehan Q; Setty BS
    Andrologia; 1977; 9(1):63-9. PubMed ID: 857707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New matrix material for potential use in "reversible" vasectomy. Preliminary animal biocompatibility studies.
    Carroll JC; Schwaitzberg SD; Ucci AA; Schlesinger RM; Lauritzen D; Sant GR
    Urology; 1993 Jan; 41(1):34-7. PubMed ID: 8420076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic changes of the vas deferens after vasectomy and vasovasostomy in dogs.
    Hamidinia A; Beck AD; Wright N
    Surg Gynecol Obstet; 1983 Jun; 156(6):737-42. PubMed ID: 6857452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.